Evidence map›Paper›PMID 33879252›Full record

ArticleBiology of sex differences2021

Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia.

Claire Richards, Kimberly Sesperez, Michael Chhor, Sahar Ghorbanpour, Claire Rennie, Clara Liu Chung Ming, Chris Evenhuis, Valentina Nikolic, Natasa Karadzov Orlic, Zeljko Mikovic and 6 more

Open access · goldAbstract read
In one paragraph

Article in Biology of sex differences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Generation and applications of cardiac spheroids.npj biomedical innovations · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Increased CaBiochemical pharmacology · 2023
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Claire RichardsSchool of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.
Kimberly SesperezSchool of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.
Michael ChhorSchool of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.
Sahar GhorbanpourSchool of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.
Claire RennieSchool of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.
Clara Liu Chung MingSchool of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology Sydney, Sydney, NSW, Australia.
Chris EvenhuisThe iThree Institute, University of Technology Sydney, Sydney, NSW, Australia.
Valentina NikolicDepartment of Pharmacology and Toxicology & Department of Internal Medicine - Gynaecology, Medical Faculty, University of Nis, Nis, Serbia.
Natasa Karadzov OrlicDepartment of Gynaecology and Obstetrics, Narodni Front, Belgrade, Serbia.
Zeljko MikovicDepartment of Gynaecology and Obstetrics, Narodni Front, Belgrade, Serbia.
Milan StefanovicDepartment of Pharmacology and Toxicology & Department of Internal Medicine - Gynaecology, Medical Faculty, University of Nis, Nis, Serbia.
Zoran CakicDepartment of Gynaecology and Obstetrics, General Hospital of Leskovac, Leskovac, Serbia.
Kristine McGrathSchool of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.
Carmine GentileSchool of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology Sydney, Sydney, NSW, Australia.
Kristen BubbThe Kolling Institute, University of Sydney, Sydney, NSW, Australia.
Lana McClementsSchool of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia. lana.mcclements@uts.edu.au.ORCID 0000-0002-4911-1014
University of Technology Sydney · AUUniversity of Belgrade · RSUniversity of Nis · RSThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPreeclampsia is a dangerous cardiovascular disorder of pregnancy that leads to an increased risk of future cardiovascular and metabolic disorders. Much of the pathogenesis and mechanisms involved in cardiac health in preeclampsia are unknown. A novel anti-angiogenic protein, FKBPL, is emerging as having a potential role in both preeclampsia and cardiovascular disease (CVD). Therefore, in this study we aimed to characterise cardiac health and FKBPL regulation in the rat reduced uterine perfusion pressure (RUPP) and a 3D cardiac spheroid model of preeclampsia.

methodsThe RUPP model was induced in pregnant rats and histological analysis performed on the heart, kidney, liver and placenta (n ≥ 6). Picrosirius red staining was performed to quantify collagen I and III deposition in rat hearts, placentae and livers as an indicator of fibrosis. RT-qPCR was used to determine changes in Fkbpl, Icam1, Vcam1, Flt1 and Vegfa mRNA in hearts and/or placentae and ELISA to evaluate cardiac brain natriuretic peptide (BNP45) and FKBPL secretion. Immunofluorescent staining was also conducted to analyse the expression of cardiac FKBPL. Cardiac spheroids were generated using human cardiac fibroblasts and human coronary artery endothelial cells and treated with patient plasma from normotensive controls, early-onset preeclampsia (EOPE) and late-onset preeclampsia (LOPE); n = 3. FKBPL and CD31 expression was quantified by immunofluorescent labelling.

resultsThe RUPP procedure induced significant increases in blood pressure (p < 0.001), collagen deposition (p < 0.001) and cardiac BNP45 (p < 0.05). It also induced a significant increase in cardiac FKBPL mRNA (p < 0.05) and protein  expression  (p < 0.01). RUPP placentae also exhibited increased collagen deposition and decreased Flt1 mRNA expression (p < 0.05). RUPP kidneys revealed an increase in average glomerular size (p < 0.05). Cardiac spheroids showed a significant increase in FKBPL expression when treated with LOPE plasma (p < 0.05) and a trend towards increased FKBPL expression following treatment with EOPE plasma (p = 0.06).

conclusionsThe rat RUPP model induced cardiac, renal and placental features reflective of preeclampsia. FKBPL was increased in the hearts of RUPP rats and cardiac spheroids treated with plasma from women with preeclampsia, perhaps reflective of restricted angiogenesis and inflammation in this disorder. Elucidation of these novel FKBPL mechanisms in cardiac health in preeclampsia could be key in preventing future CVD.

Indexed as

Pre-EclampsiaAnimalsCollagenEndothelial CellsFemaleHumansPerfusionPlacentaPregnancyPregnancy Complications, CardiovascularRatsRats, Sprague-DawleyRNA, MessengerSex CharacteristicsTacrolimus Binding ProteinsCollagenFKBPL protein, humanRNA, MessengerTacrolimus Binding ProteinsCardiac spheroidsCardiovascular diseaseFKBPLPreeclampsiaReduced uterine perfusion pressure

Identifiers

PMID33879252
PMCPMC8056582
OpenAlexW3118273393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.